| Name | Title | Contact Details |
|---|
MediStreams provides outsourced Healthcare Revenue Cycle Management (RCM) services for healthcare providers such as health systems, hospitals, clinics, physician groups, labs, and clinics. Despite significant advances in technology, RCM in the United States is unique and extremely complex. Although there has been a push for insurance payments to be made electronically, there are still many that arrive in the form of paper Explanation of Benefits (EOBs) combined with a traditional paper check. The Electronic Remittance Advice (ERAs) do arrive electronically and the funds are deposited to the provider`s bank, but they still must be managed and combined with other payment types to create a file that can be posted into the providers practice management software. MediStreams is now helping the industry embrace new payment technologies that leverage existing credit pipes while managing protected healthcare information. MediStreams` process automates the flow of healthcare payments by creating electronic files customized specifically to post directly to the provider`s practice management system. MediStreams` unique service delivery model accelerates the posting of remittances while eliminating errors associated with manual processing which significantly reduces provider overhead costs. MediStreams` fully HIPAA compliant platform also provides the means for payers to provide a fully reconciled payment to providers in compliance with Section 1104 of the Affordable Care Act (ACA).
LearnWright is a Potomac, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Specialists of the Palm Beaches is a primary care focused, multi-specialty physician group practice serving Palm Beach and Broward counties in Florida. They offer primary care, cardiology, neurology, hematology/oncology, concierge medicine, and...
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Greater Houston Anesthesiology (GHA) is a Texas professional association dedicated to being the leading provider of perioperative and anesthesiology services in the Houston area. GHA began operations on January 1, 1996, following the merger of six